NCT07502391

Brief Summary

Postoperative delirium is a common and serious complication after surgery, affecting 10-40% of older patients undergoing non-cardiac procedures. It is characterized by sudden changes in attention, awareness, and thinking that fluctuate throughout the day. Delirium is associated with longer hospital stays, higher mortality, worse long-term brain function, and substantially increased healthcare costs. While several risk factors are known, it remains unclear whether a patient's sex independently influences the risk of developing postoperative delirium, as existing studies have produced conflicting results and were often not designed to specifically examine sex differences.Family visitation is a promising non-drug approach to preventing delirium. Studies in intensive care patients have shown that those who receive family visits have a significantly lower risk of developing delirium. However, it is unknown whether men and women receive different amounts of family visits after surgery, and whether any such difference could help explain sex-based disparities in delirium risk. Given that traditional gender roles in caregiving persist, women - who often serve as primary caregivers in their families - may receive fewer visits when they themselves become patients.This prospective observational study led by the University of Zurich will enroll 471 patients aged 65 years or older undergoing non-cardiac surgery lasting at least 2 hours under general or spinal anesthesia. The primary aim is to determine whether female patients have a higher risk of developing postoperative delirium within three days after surgery compared to male patients. Delirium will be assessed twice daily using the 4 A's Test (4AT), a validated and standardized screening tool. The secondary aim is to evaluate whether female patients receive fewer family visits than male patients and whether any difference in visitation mediates the sex-dependent delirium risk. Family visits will be recorded using an anonymous sign-in sheet placed in the patient's room. The study does not involve any experimental interventions; all patients receive standard clinical care. Participation is voluntary, and withdrawal is possible at any time without affecting medical treatment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
471

participants targeted

Target at P75+ for all trials

Timeline
29mo left

Started May 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress9%
May 2026Dec 2028

First Submitted

Initial submission to the registry

March 25, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 31, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

May 5, 2026

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

June 1, 2026

Status Verified

March 1, 2026

Enrollment Period

2.7 years

First QC Date

March 25, 2026

Last Update Submit

May 27, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative Delirium

    The primary outcome is presence of delirium as assessed by the 4AT test. A 4AT score of 4 or above will be used for dichotomous assessment of the primary outcome presence of delirium. Participants will be assessed daily in the morning and the evening.

    Starting on postoperative day (POD) 1 and continuing until POD 3, or discharge - whichever comes first.

Secondary Outcomes (1)

  • Family Visits

    Starting on postoperative day (POD) 1 and continuing until POD 3, or discharge - whichever comes first

Study Arms (2)

Female

Female patients aged 65 years or above with scheduled non-cardiac surgery with expected surgery duration ≥ 2 hours under either general or spinal anesthesia.

Male

Male patients aged 65 years or above with scheduled non-cardiac surgery with expected surgery duration ≥ 2 hours under either general or spinal anesthesia.

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients aged 65 and older who are having noncardiac surgery

You may qualify if:

  • Informed consent as documented by signature;
  • ≥65 years of age;
  • Scheduled non-cardiac surgery with expected surgery duration ≥ 2 hours;
  • Under either general or spinal anesthesia.

You may not qualify if:

  • Known drug or alcohol abuse;
  • Requirement for postoperative ventilation;
  • Current participation in another study with an investigational drug;
  • Inability to complete the study assessments.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitätsspital Zürich

Zurich, Switzerland

RECRUITING

MeSH Terms

Conditions

Emergence Delirium

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Attending Physician, Institute of Anesthesiology and Perioperative Medicine

Study Record Dates

First Submitted

March 25, 2026

First Posted

March 31, 2026

Study Start

May 5, 2026

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

June 1, 2026

Record last verified: 2026-03

Locations